Wockhardt Limited is a leading global pharmaceutical and biotechnology company headquartered in Mumbai, India. The company is primarily focused on the discovery and development of novel antibiotics to address the global threat of antimicrobial resistance (AMR). Wockhardt has a significant presence in the fields of formulations, biopharmaceuticals, and active pharmaceutical ingredients (APIs), with a strong emphasis on therapeutic areas such as anti-infectives, diabetes, and respiratory health. In recent years, Wockhardt has transitioned from a generics-focused business to an innovation-driven enterprise, notably exiting its US generics business in 2024 to focus on its proprietary pipeline. The company operates research and manufacturing facilities across India, the UK, Ireland, and the US, and is one of the few Indian firms to have successfully moved multiple New Chemical Entities (NCEs) through global clinical trials.
CLASSIFICATION
Company Type:Pharma
Industry:Pharmaceuticals
Sub-Industry:Anti-infectives and Biotechnology
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$300M-$400M
Founded:1967
Ownership:public
Status:operating
FUNDING
Stage:Public
Total Raised:$1.0B+
Investors:Public Shareholders, Promoter Group (Khorakiwala Family), Institutional Investors (via QIP)
STOCK
Exchange:NSE
Ticker:WOCKPHARMA
Market Cap:$2.7B
PIPELINE
Stage:Commercial
Lead Drug Stage:NDA Submitted (US FDA)
Modalities:Small molecule, Biosimilars, Insulin, Vaccines
Active Trials:8
Trial Phases:Phase 1: 2 | Phase 2: 3 | Phase 3: 3
FDA Approvals:15
EMA Approvals:10
CORPORATE STRUCTURE
Subsidiaries:Wockhardt UK, Wockhardt Bio AG, Pinewood Healthcare, Wockhardt USA LLC
Key Partnerships:Serum Institute of India (Vaccine manufacturing), EnnoVant (Licensing for certain territories)
COMPETITION
Position:Challenger
Competitors:Sun Pharma, Lupin, Cipla, Aurobindo Pharma, Merck (Antibiotics division)
LEADERSHIP
Key Executives:
Dr. Habil Khorakiwala - Founder Chairman
Dr. Murtaza Khorakiwala - Managing Director
Deepak Madnani - CFO
Scientific Founders:Dr. Habil Khorakiwala
Board Members:Akhilesh Gupta, Vinesh Jairath, Ahmad Javed, Zahabiya Khorakiwala
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Wockhardt. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.